These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7275854)

  • 41. Antibacterial activities of new nitrofuran derivatives on Mycoplasm gallisepticum and Haemophilus gallinarum.
    Ota S; Watanabe S; Kuniyasu C
    Natl Inst Anim Health Q (Tokyo); 1970; 10(1):1-10. PubMed ID: 4191833
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro testing of the anti-mycoplasma effect of some anti-coccidial drugs.
    Stipkovits L; Kobulej T; Varga Z; Juhász S
    Vet Microbiol; 1987 Oct; 15(1-2):65-70. PubMed ID: 3439016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy trials in turkey poults with tylosin tartrate against Mycoplasma gallisepticum and Mycoplasma meleagridis.
    Wise DR; Fuller MK
    Res Vet Sci; 1975 Nov; 19(3):338-9. PubMed ID: 1215688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biological activity of megalomicin, a new Micromonospora-produced macrolide antibiotic complex.
    Waitz JA; Moss EL; Oden EM; Weinstein MJ
    J Antibiot (Tokyo); 1969 Jun; 22(6):265-72. PubMed ID: 4390258
    [No Abstract]   [Full Text] [Related]  

  • 46. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
    Yancey RJ; Klein LK
    J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological properties of new acyl derivatives of tylosin.
    Okamoto R; Tsuchiya M; Nomura H; Iguchi H; Kiyoshima K; Hori S; Inui T; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1309-15. PubMed ID: 7251472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the antimycoplasma activity of two commercially available tylosin premixes.
    Ose EE; Tonkinson LV
    Poult Sci; 1985 Feb; 64(2):287-93. PubMed ID: 3991415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Further observations on the sensitivity to the antibiotics of some mycoplasma associated with bovine mastitis].
    Marca G; Bertoldini G; Socci A
    Arch Vet Ital; 1970 Dec; 21(6):413-9. PubMed ID: 5518812
    [No Abstract]   [Full Text] [Related]  

  • 50. Megalomicin, a new macrolide antibiotic complex produced by Micromonospora.
    Weinstein MJ; Wagman GH; Marquez JA; Testa RT; Oden E; Waitz JA
    J Antibiot (Tokyo); 1969 Jun; 22(6):253-8. PubMed ID: 5810991
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro comparison of the activity of various antibiotics and drugs against new Taiwan isolates and standard strains of avian mycoplasma.
    Lin MY
    Avian Dis; 1987; 31(4):705-12. PubMed ID: 3442523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic.
    Ose EE
    J Antibiot (Tokyo); 1987 Feb; 40(2):190-4. PubMed ID: 3570967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antibiotic sensitivity of Mycoplasma pathogenic for man].
    Quentin C; Cantet P; Renaudin H; Bebear C
    Pathol Biol (Paris); 1985 Mar; 33(3):205-12. PubMed ID: 3892448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro sensitivity of mycoplasmas isolated from various animals and sewage to antibiotics and nitrofurans.
    Ogata M; Atobe H; Kushida H; Yamamoto K
    J Antibiot (Tokyo); 1971 Jul; 24(7):443-51. PubMed ID: 4327309
    [No Abstract]   [Full Text] [Related]  

  • 55. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
    Rolston KV; LeBlanc B; Ho DH
    J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro activity of sparfloxacin against mycoplasmas].
    Renaudin H; Bebear C
    Pathol Biol (Paris); 1992 May; 40(5):450-4. PubMed ID: 1323094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spiramycin, a macrolide antibiotic.
    Abou-Zeid AZ; Khalil A el-G ; Rabei M
    Zentralbl Bakteriol Naturwiss; 1980; 135(5):443-53. PubMed ID: 6779436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of an erythromycin-resistant strain of Mycoplasma pneumoniae for the fermentation-inhibition test.
    Niitu Y; Hasegawa S; Kubota H
    Antimicrob Agents Chemother; 1974 Feb; 5(2):111-3. PubMed ID: 4840426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on a new antibiotic M-92 produced by Micromonospora. III. Biological activities.
    Tani K; Arai Y; Yamaguchi T
    J Antibiot (Tokyo); 1982 Nov; 35(11):1441-7. PubMed ID: 7161183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative.
    Drews J; Georgopoulos A; Laber G; Schütze E; Unger J
    Antimicrob Agents Chemother; 1975 May; 7(5):507-16. PubMed ID: 1170807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.